Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice

Dan Zhang(China-Japan Friendship Hospital), Lanqing Ma(Kunming Medical University)
Frontiers in Pharmacology
January 19, 2022
Cited by 10


Related Papers